Cargando…

Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality

BACKGROUND: Although the effects of fine particulate matter (particulate matter ≤2.5 μm aerodynamic diameter [PM(2.5)]) on cardiovascular disease (CVD) morbidity and mortality are well established, little is known about the CVD health effects of particle radioactivity. In addition, there are still q...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuxin, Koutrakis, Petros, Li, Longxiang, Coull, Brent A., Schwartz, Joel, Kosheleva, Anna, Zanobetti, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673676/
https://www.ncbi.nlm.nih.gov/pubmed/36197036
http://dx.doi.org/10.1161/JAHA.121.025470
_version_ 1784832995437314048
author Dong, Shuxin
Koutrakis, Petros
Li, Longxiang
Coull, Brent A.
Schwartz, Joel
Kosheleva, Anna
Zanobetti, Antonella
author_facet Dong, Shuxin
Koutrakis, Petros
Li, Longxiang
Coull, Brent A.
Schwartz, Joel
Kosheleva, Anna
Zanobetti, Antonella
author_sort Dong, Shuxin
collection PubMed
description BACKGROUND: Although the effects of fine particulate matter (particulate matter ≤2.5 μm aerodynamic diameter [PM(2.5)]) on cardiovascular disease (CVD) morbidity and mortality are well established, little is known about the CVD health effects of particle radioactivity. In addition, there are still questions about which of the PM(2.5) physical, chemical, or biological properties are mostly responsible for its toxicity. METHODS AND RESULTS: We investigated the association between particle radioactivity, measured as gross β activity from highly resolved spatiotemporal predictions, and mortality for CVD, myocardial infarction, stroke, and all‐cause nonaccidental mortality in Massachusetts (2001–2015). Within both difference‐in‐differences model and generalized linear mixed model frameworks, we fit both single‐exposure and 2‐exposure models adjusting for PM(2.5) and examined the interaction between PM(2.5) and gross β activity. We found significant associations between gross β activity and PM(2.5) and each mortality cause. Using difference‐in‐differences and adjusting for PM(2.5), we found the highest associations with myocardial infarction (rate ratio, 1.16 [95% CI, 1.08–1.24]) and stroke (rate ratio, 1.11 [95% CI, 1.04–1.18]) for an interquartile range increase (0.055 millibecquerels per cubic meter) in gross β activity. We found a significant positive interaction between PM(2.5) and gross β activity, with higher associations between PM(2.5) and mortality at a higher level of gross β activity. We also observed that the associations varied across age groups. The results were comparable between the 2 statistical methods also with and without adjusting for PM(2.5). CONCLUSIONS: This is the first study that, using highly spatiotemporal predictions of gross β‐activity, provides evidence that particle radioactivity increases CVD mortality and enhances PM(2.5) CVD mortality. Therefore, particle radioactivity can be an important property of PM(2.5) that must be further investigated. Addressing this important question can lead to cost‐effective air‐quality regulations.
format Online
Article
Text
id pubmed-9673676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96736762022-11-21 Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality Dong, Shuxin Koutrakis, Petros Li, Longxiang Coull, Brent A. Schwartz, Joel Kosheleva, Anna Zanobetti, Antonella J Am Heart Assoc Original Research BACKGROUND: Although the effects of fine particulate matter (particulate matter ≤2.5 μm aerodynamic diameter [PM(2.5)]) on cardiovascular disease (CVD) morbidity and mortality are well established, little is known about the CVD health effects of particle radioactivity. In addition, there are still questions about which of the PM(2.5) physical, chemical, or biological properties are mostly responsible for its toxicity. METHODS AND RESULTS: We investigated the association between particle radioactivity, measured as gross β activity from highly resolved spatiotemporal predictions, and mortality for CVD, myocardial infarction, stroke, and all‐cause nonaccidental mortality in Massachusetts (2001–2015). Within both difference‐in‐differences model and generalized linear mixed model frameworks, we fit both single‐exposure and 2‐exposure models adjusting for PM(2.5) and examined the interaction between PM(2.5) and gross β activity. We found significant associations between gross β activity and PM(2.5) and each mortality cause. Using difference‐in‐differences and adjusting for PM(2.5), we found the highest associations with myocardial infarction (rate ratio, 1.16 [95% CI, 1.08–1.24]) and stroke (rate ratio, 1.11 [95% CI, 1.04–1.18]) for an interquartile range increase (0.055 millibecquerels per cubic meter) in gross β activity. We found a significant positive interaction between PM(2.5) and gross β activity, with higher associations between PM(2.5) and mortality at a higher level of gross β activity. We also observed that the associations varied across age groups. The results were comparable between the 2 statistical methods also with and without adjusting for PM(2.5). CONCLUSIONS: This is the first study that, using highly spatiotemporal predictions of gross β‐activity, provides evidence that particle radioactivity increases CVD mortality and enhances PM(2.5) CVD mortality. Therefore, particle radioactivity can be an important property of PM(2.5) that must be further investigated. Addressing this important question can lead to cost‐effective air‐quality regulations. John Wiley and Sons Inc. 2022-10-05 /pmc/articles/PMC9673676/ /pubmed/36197036 http://dx.doi.org/10.1161/JAHA.121.025470 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Dong, Shuxin
Koutrakis, Petros
Li, Longxiang
Coull, Brent A.
Schwartz, Joel
Kosheleva, Anna
Zanobetti, Antonella
Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title_full Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title_fullStr Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title_full_unstemmed Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title_short Synergistic Effects of Particle Radioactivity (Gross β Activity) and Particulate Matter ≤2.5 μm Aerodynamic Diameter on Cardiovascular Disease Mortality
title_sort synergistic effects of particle radioactivity (gross β activity) and particulate matter ≤2.5 μm aerodynamic diameter on cardiovascular disease mortality
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673676/
https://www.ncbi.nlm.nih.gov/pubmed/36197036
http://dx.doi.org/10.1161/JAHA.121.025470
work_keys_str_mv AT dongshuxin synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT koutrakispetros synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT lilongxiang synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT coullbrenta synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT schwartzjoel synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT koshelevaanna synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality
AT zanobettiantonella synergisticeffectsofparticleradioactivitygrossbactivityandparticulatematter25mmaerodynamicdiameteroncardiovasculardiseasemortality